CJC-1295 (no DAC) + Ipamorelin Blend 10mg
Laboratory and analytical research only. Not for human consumption. 18+.
- Available to order
- Free UK tracked delivery
- Find product documents
Paid orders before 3pm UK time normally dispatch the same working day. Later orders dispatch the next working day. Excludes UK public holidays.
Pay by Bank with Wallid
We currently accept Pay by Bank via Wallid. Authorise the payment with your bank at checkout.
How Pay by Bank works
- Check your order and delivery details at checkout.
- Continue to Wallid, select your bank and follow the steps to authorise payment.
- Return to the store after authorising payment. Payment must be received before dispatch.
Unsure whether payment went through? Contact us before trying again. Contact us
Questions before you order? Contact us
Specification and laboratory information
✓ Verified peptide quality
✓ ≥99% purity by HPLC
✓ Current test certificate available
✓ Held in UK stock
✓ Free Royal Mail 24 Tracked delivery
✓ Orders before 3pm dispatched the same working day
A dual-compound lyophilised preparation containing CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin, co-lyophilised in a single vial and supplied for laboratory research.
Fill split: Total fill 10mg (5mg CJC no DAC + 5mg Ipamorelin)
Note on nomenclature. "CJC-1295" is used commercially for two chemically distinct molecules. This blend contains the 29-residue non-DAC compound — properly Mod GRF (1-29), originally designated tetrasubstituted GRF (1-29) — at approximately 3,368 g/mol. It does not contain the 30-residue DAC-conjugated compound at approximately 3,647 g/mol, which we stock separately. If your work requires the DAC variant, order that product instead.
Three CJC-1295 and Ipamorelin products — which is which?
We stock three products covering these compounds - this is the highlighted bottom of the three below.
The naming in this market is genuinely confusing, so here's the plain version:
| Product | Contains | Key mass |
|---|---|---|
| CJC-1295 with DAC 10mg | The 30-residue DAC-conjugated compound, alone | ~3,647 g/mol |
| Ipamorelin 10mg | The pentapeptide, alone | 711.85 g/mol |
| CJC-1295 no DAC + Ipamorelin Blend | The 29-residue non-DAC compound (Mod GRF 1-29) plus Ipamorelin, co-lyophilised | ~3,368 + 711.85 g/mol |
The DAC distinction is the one that catches people out. "CJC-1295" is sold as two different molecules: with DAC (30 residues, ~3,647 g/mol, a maleimidopropionyl group on the C-terminal lysine) and without DAC (29 residues, ~3,368 g/mol, no conjugation — properly called Mod GRF 1-29). Roughly 280 Da apart, same commercial name.
Worse, the CAS number most suppliers publish for "CJC-1295" is 863288-34-0, which properly denotes the non-DAC compound. If you've ordered "CJC-1295" elsewhere against that CAS and received the DAC version, or vice versa, that's where it went wrong.
Constituent identity
| CJC-1295 no DAC | Ipamorelin | |
|---|---|---|
| Proper name | Mod GRF (1-29) | Ipamorelin |
| CAS number | 863288-34-0 | 170851-70-4 |
| Molecular formula | C₁₅₂H₂₅₂N₄₄O₄₂ | C₃₈H₄₉N₉O₅ |
| Molecular weight | 3367.95 g/mol | 711.85 g/mol |
| Residue count | 29, C-terminal amide | 5, C-terminal amide |
| Compound class | GHRH(1-29) analogue | Synthetic pentapeptide |
| UNII | — | Y9M3S784Z6 |
| Also indexed as | CJC-1295 without DAC, Modified GRF (1-29), tetrasubstituted GRF (1-29) | NNC 26-0161 |
CJC-1295 no DAC sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Four substitutions distinguish it from native GRF(1-29): D-Ala at position 2, Gln at 8, Ala at 15, and Leu at 27. Hence the original name, tetrasubstituted GRF (1-29).
Ipamorelin sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Contains three non-standard residues — α-aminoisobutyric acid (Aib), D-2-naphthylalanine and D-phenylalanine — which is what distinguishes it analytically from conventional L-peptides of comparable mass.
Product specification
| Nominal fill | 10mg |
| Split | 5mg CJC1295 no DAC & 5mg Ipamorelin |
| Identity confirmation | Mass spectrometry, both compounds |
| Physical form | Co-lyophilised powder |
| Appearance | White to off-white |
| Vial | Sealed glass, single unit |
| Documentation | Lot COA reporting each compound separately |
Storage and handling
Store the sealed vial at −20°C, desiccated and protected from light. Equilibrate fully to ambient temperature before opening to prevent condensation on the powder.
Two handling points specific to this preparation:
A blend cannot be separated after preparation. The ratio in the vial is fixed. If your work needs independent control of either concentration, order the single-compound products.
Mind the mass difference when interpreting the COA. At 3,368 and 712 g/mol, the two constituents differ by roughly a factor of 4.7. Equal masses are not equal molar quantities — the lighter peptide contributes substantially more moles per milligram. Read the certificate accordingly.
Supply and despatch
Held in UK stock. Orders placed before 3pm on a working day are despatched the same day by Royal Mail 24 Tracked. No import delay, no customs handling.
FAQ
What's the difference between CJC-1295 with and without DAC? The DAC version carries a maleimidopropionyl group on a 30th C-terminal lysine residue, at approximately 3,647 g/mol. The non-DAC version is the 29-residue peptide alone, approximately 3,368 g/mol, properly named Mod GRF (1-29). This blend contains the non-DAC compound.
Is CJC-1295 no DAC the same as Mod GRF 1-29? Yes. Mod GRF (1-29) is the accurate name; "CJC-1295 no DAC" is the common commercial one. Both refer to the 29-residue tetrasubstituted GRF(1-29) analogue, CAS 863288-34-0.
Does the certificate of analysis cover both compounds? Yes — purity and identity are reported separately for each constituent, not as a combined figure.
Can I buy the two compounds separately? Ipamorelin and CJC1295 with DAC are stocked as a single-compound 10mg vial.
Why does the CAS number differ from other suppliers' CJC-1295 listings? Because many listings are wrong. CAS 863288-34-0 denotes the 29-residue non-DAC compound. Suppliers routinely publish it against the DAC product, which is a different molecule with a different mass.